Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results

Go back to Krystal Biotech Announces Second Quarter 2025 Financial and Operating Results
(NASDAQ: KRYS) Delayed: 358.89 -12.58 (3.39%)
Previous Close $371.47    52 Week High
Open $365.45    52 Week Low
Day High $371.99    P/E N/A 
Day Low $358.51    EPS
Volume 88,771